MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-03-2022
Abiomed Operating Expenses 2011-2026 | ABMD
Annual Operating Expenses Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 456 M | 440 M | 415 M | 338 M | 285 M | 214 M | 162 M | 138 M | 110 M | 100 M | 90.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 456 M | 90.4 M | 250 M |
Quarterly Operating Expenses Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 132 M | 119 M | 110 M | 94.8 M | 109 M | 111 M | 110 M | 110 M | 107 M | 104 M | 102 M | 102 M | 96.8 M | 84.3 M | 79.5 M | 77.5 M | 76.4 M | 70.3 M | 71.1 M | 66.7 M | 59.5 M | 55.6 M | 51.4 M | 47.5 M | 44.4 M | 38.5 M | 38.1 M | 40.7 M | 36.6 M | 32.1 M | 33.9 M | 35.3 M | 30.7 M | 27.2 M | 24.3 M | 27.8 M | 27.6 M | 23.7 M | 23.2 M | 25.9 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 132 M | 23.2 M | 66.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M |  USA |
 |
Alphatec Holdings
ATEC
|
560 M | $ 21.04 | 0.86 % | $ 3.01 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 9.39 | 0.97 % | $ 674 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.54 | 2.91 % | $ 123 M | USA |
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 95.46 | -0.55 % | $ 140 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 302.69 | -0.7 % | $ 8.54 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 47.37 | -0.29 % | $ 7.06 K | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 125.42 | -0.31 % | $ 218 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.29 | 2.34 % | $ 123 M |  France |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 29.28 | 1.1 % | $ 248 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
136 M | $ 14.75 | -0.64 % | $ 1.17 B | Israel |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Zynex
ZYXI
|
69.9 M | - | - | $ 21.1 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 156.53 | -1.02 % | $ 11.7 B | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.82 | 2.08 % | $ 84.3 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.5 | -0.52 % | $ 365 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.58 | -0.13 % | $ 122 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 32.74 | 0.03 % | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.12 | -2.61 % | $ 18.1 M | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 97.43 | -0.35 % | $ 1.23 B | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 40.65 | -1.2 % | $ 1.25 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
184 M | $ 17.74 | -1.25 % | $ 409 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 87.52 | -0.4 % | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 12.42 | -2.09 % | $ 956 M | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.73 | 1.49 % | $ 4.26 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 61.42 | -1.39 % | $ 3.33 B |  Britain |